Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Mitigating stress-related cell loss in islet replacement therapy for type 1 diabetes (T1D)

    Mitigating stress-related cell loss in islet replacement therapy for type 1 diabetes (T1D) supports academic and industry investigators developing ways to reduce transplant cell loss for more durable therapies.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Project #87: Leveraging circadian biology to enhance the function and the survival of transplanted human stem cell-derived ß-cells for the treatment of T1D

    This Diabetes Research Connection grant supports research into how circadian biology can improve the survival and function of transplanted stem cell-derived beta cells for type 1 diabetes therapy.

    DRCRolling submissions$75,000

    Project #80: Nano-in-microgel long-acting combination drug delivery platform for localized immunomodulation to prevent allogenic islet graft immune rejection in extrahepatic transplantation sites

    Project #80 supports Dr. Dhanashree Surve’s research on localized combination drug delivery to protect transplanted islet cells from immune rejection and reduce reliance on lifelong immunosuppression.

    DRCForecasted Jul 31, 2027$75,000Forecasted

    Project #72: Optogenetics to stimulate maturation of functional replacement beta cells from human stem cells

    This grant funds research using optogenetics to mature stem cell-derived beta cells for improved type 1 diabetes therapy, supported by the Diabetes Research Connection.

    DRCRolling submissions$75,000

    Project #76: Assessing spatial heterogeneity of the alpha cell dysfunction and testing its connection to the islet-specific T cells in T1D

    Project #76 supports Vira Kravets at UC San Diego in studying alpha cell dysfunction and immune targeting as possible triggers of type 1 diabetes, potentially informing prevention and treatment.

    DRCForecasted Jul 31, 2027$75,000Forecasted

    Project #85: BNIP3-Mediated Mitophagy Regulates ß-Cell Identity and Immunogenicity in T1D

    This grant supports research on how BNIP3-mediated mitophagy affects beta cell identity and immune response in type 1 diabetes, aiming to uncover new therapeutic approaches.

    DRCRolling submissions$75,000